Berger Mark Stanley 4

4 · Actinium Pharmaceuticals, Inc. · Filed Mar 7, 2019

Insider Transaction Report

Form 4
Period: 2019-03-05
Berger Mark Stanley
Chief Medical Officer
Transactions
  • Exercise of In-Money

    Common Stock

    2019-03-05$0.60/sh+3,500$2,10022,500 total

Documents

1 file
  • 4
    ownership.xmlPrimary